TLR3 and pulmonary arterial hypertension: In summary, the study demonstrated for the first time that reduced TLR3 expression is present in the lung tissue and endothelial cells of patients with PAH, both in vitro and in vivo, which leads to increased cell susceptibility to apoptosis and the development of PAH.